CHGCF:OTCMKTS
Chugai Pharmaceutical Co Ltd
US$38,27
arrow_upward
+1,13%(+0,43) 1D
2 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCF...
Open
US$39,92
High
US$39,92
Low
US$37,45
Mkt. cap
10,16ລລ
Avg. vol.
10,10 ພັນ
Volume
11,44 ພັນ
52-wk high
US$68,08
52-wk low
US$34,79
Beta
1,91
Shares outstanding
1,68 ຕື້
No. of employees
5 ພັນ
Open
US$39,92
High
US$39,92
Low
US$37,45
Mkt. cap
10,16ລລ
Avg. vol.
10,10 ພັນ
Volume
11,44 ພັນ
52-wk high
US$68,08
52-wk low
US$34,79
Beta
1,91
Shares outstanding
1,68 ຕື້
No. of employees
5 ພັນ
News stories
From web sources and news partners
Proactive financial news
·
52 ນາທີກ່ອນ
Nova Minerals to host investor webinar on Estelle and US antimony strategy
Yahoo! Finance Canada
·
12 ນາທີກ່ອນ
AMN,HLF,PGY,BSBK,FXNC,IMRX,CRMT,MRBK,ORN,TISI,FRST,GRNT,VSTS,GEF-B,RVSB,TMCI,DCGO,SABR,BCRX,SHEN,NBBK,USCB | Stock Prices | Quote Comparison
Stock Traders Daily
·
4 ຊົ່ວໂມງກ່ອນ
Avoiding Lag: Real-Time Signals in (XLSR) Movement
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5,1 ພັນ
Founded10 ມ.ນ. 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp